Ernexa Therapeutics Inc. Stock Issued During Period, Shares, Purchase of Assets
Ernexa Therapeutics Inc. (ERNA) reported Stock Issued During Period, Shares, Purchase of Assets of 44 shares for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets · last filed 2016-11-09
- 2016-06-30: Stock Issued During Period, Shares, Purchase of Assets 6 month 44.00 shares.
- 2015-09-30: Stock Issued During Period, Shares, Purchase of Assets 9 month 40.00 shares.
| Period end | Stock Issued During Period, Shares, Purchase of Assets 6 month | Stock Issued During Period, Shares, Purchase of Assets 9 month |
|---|---|---|
| 2016-06-30 | 44.00 shares 10-Q · filed 2016-08-04 | |
| 2015-09-30 | 40.00 shares 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |